UniProt ID | SP1_HUMAN | |
---|---|---|
UniProt AC | P08047 | |
Protein Name | Transcription factor Sp1 | |
Gene Name | SP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 785 | |
Subcellular Localization | Nucleus. Cytoplasm. Nuclear location is governed by glycosylated/phosphorylated states. Insulin promotes nuclear location, while glucagon favors cytoplasmic location. | |
Protein Description | Transcription factor that can activate or repress transcription in response to physiological and pathological stimuli. Binds with high affinity to GC-rich motifs and regulates the expression of a large number of genes involved in a variety of processes such as cell growth, apoptosis, differentiation and immune responses. Highly regulated by post-translational modifications (phosphorylations, sumoylation, proteolytic cleavage, glycosylation and acetylation). Binds also the PDGFR-alpha G-box promoter. May have a role in modulating the cellular response to DNA damage. Implicated in chromatin remodeling. Plays an essential role in the regulation of FE65 gene expression. In complex with ATF7IP, maintains telomerase activity in cancer cells by inducing TERT and TERC gene expression. Isoform 3 is a stronger activator of transcription than isoform 1. Positively regulates the transcription of the core clock component ARNTL/BMAL1. [PubMed: 10391891] | |
Protein Sequence | MSDQDHSMDEMTAVVKIEKGVGGNNGGNGNGGGAFSQARSSSTGSSSSTGGGGQESQPSPLALLAATCSRIESPNENSNNSQGPSQSGGTGELDLTATQLSQGANGWQIISSSSGATPTSKEQSGSSTNGSNGSESSKNRTVSGGQYVVAAAPNLQNQQVLTGLPGVMPNIQYQVIPQFQTVDGQQLQFAATGAQVQQDGSGQIQIIPGANQQIITNRGSGGNIIAAMPNLLQQAVPLQGLANNVLSGQTQYVTNVPVALNGNITLLPVNSVSAATLTPSSQAVTISSSGSQESGSQPVTSGTTISSASLVSSQASSSSFFTNANSYSTTTTTSNMGIMNFTTSGSSGTNSQGQTPQRVSGLQGSDALNIQQNQTSGGSLQAGQQKEGEQNQQTQQQQILIQPQLVQGGQALQALQAAPLSGQTFTTQAISQETLQNLQLQAVPNSGPIIIRTPTVGPNGQVSWQTLQLQNLQVQNPQAQTITLAPMQGVSLGQTSSSNTTLTPIASAASIPAGTVTVNAAQLSSMPGLQTINLSALGTSGIQVHPIQGLPLAIANAPGDHGAQLGLHGAGGDGIHDDTAGGEEGENSPDAQPQAGRRTRREACTCPYCKDSEGRGSGDPGKKKQHICHIQGCGKVYGKTSHLRAHLRWHTGERPFMCTWSYCGKRFTRSDELQRHKRTHTGEKKFACPECPKRFMRSDHLSKHIKTHQNKKGGPGVALSVGTLPLDSGAGSEGSGTATPSALITTNMVAMEAICPEGIARLANSGINVMQVADLQSINISGNGF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSDQDHSMD ------CCCCCCCHH | 43.93 | 20068231 | |
2 | Phosphorylation | ------MSDQDHSMD ------CCCCCCCHH | 43.93 | 29255136 | |
7 | Phosphorylation | -MSDQDHSMDEMTAV -CCCCCCCHHHEEEE | 35.90 | 29255136 | |
12 | Phosphorylation | DHSMDEMTAVVKIEK CCCHHHEEEEEEEEC | 17.79 | 29255136 | |
16 | Sumoylation | DEMTAVVKIEKGVGG HHEEEEEEEECCCCC | 38.25 | - | |
16 | Sumoylation | DEMTAVVKIEKGVGG HHEEEEEEEECCCCC | 38.25 | 28112733 | |
19 | Acetylation | TAVVKIEKGVGGNNG EEEEEEECCCCCCCC | 63.47 | 25953088 | |
36 | Phosphorylation | GNGGGAFSQARSSST CCCCCCCCCCCCCCC | 23.54 | 26714015 | |
36 (in isoform 3) | Phosphorylation | - | 23.54 | 28634120 | |
40 | Phosphorylation | GAFSQARSSSTGSSS CCCCCCCCCCCCCCC | 31.49 | 23401153 | |
40 (in isoform 3) | Phosphorylation | - | 31.49 | 28634120 | |
41 | Phosphorylation | AFSQARSSSTGSSSS CCCCCCCCCCCCCCC | 26.77 | 30278072 | |
42 | Phosphorylation | FSQARSSSTGSSSST CCCCCCCCCCCCCCC | 37.73 | 30278072 | |
43 | Phosphorylation | SQARSSSTGSSSSTG CCCCCCCCCCCCCCC | 42.93 | 30278072 | |
45 | Phosphorylation | ARSSSTGSSSSTGGG CCCCCCCCCCCCCCC | 27.43 | 25463755 | |
45 (in isoform 3) | Phosphorylation | - | 27.43 | 28634120 | |
46 | Phosphorylation | RSSSTGSSSSTGGGG CCCCCCCCCCCCCCC | 29.65 | 30278072 | |
47 | Phosphorylation | SSSTGSSSSTGGGGQ CCCCCCCCCCCCCCC | 33.35 | 30278072 | |
48 | Phosphorylation | SSTGSSSSTGGGGQE CCCCCCCCCCCCCCC | 32.78 | 30278072 | |
49 | Phosphorylation | STGSSSSTGGGGQES CCCCCCCCCCCCCCC | 41.62 | 30278072 | |
52 | Phosphorylation | SSSSTGGGGQESQPS CCCCCCCCCCCCCCC | 35.64 | 32142685 | |
56 | Phosphorylation | TGGGGQESQPSPLAL CCCCCCCCCCCHHHH | 39.23 | 17609267 | |
59 | Phosphorylation | GGQESQPSPLALLAA CCCCCCCCHHHHHHH | 25.55 | 25159151 | |
67 | Phosphorylation | PLALLAATCSRIESP HHHHHHHHHHCCCCC | 12.85 | 30278072 | |
69 | Phosphorylation | ALLAATCSRIESPNE HHHHHHHHCCCCCCC | 31.75 | 30278072 | |
71 (in isoform 3) | Phosphorylation | - | 3.36 | 28634120 | |
73 | Phosphorylation | ATCSRIESPNENSNN HHHHCCCCCCCCCCC | 30.56 | 20873877 | |
78 | Phosphorylation | IESPNENSNNSQGPS CCCCCCCCCCCCCCC | 31.07 | 20873877 | |
81 | Phosphorylation | PNENSNNSQGPSQSG CCCCCCCCCCCCCCC | 40.54 | 20873877 | |
85 | Phosphorylation | SNNSQGPSQSGGTGE CCCCCCCCCCCCCCC | 43.75 | 26074081 | |
87 | Phosphorylation | NSQGPSQSGGTGELD CCCCCCCCCCCCCCC | 43.45 | 26074081 | |
90 | Phosphorylation | GPSQSGGTGELDLTA CCCCCCCCCCCCEEE | 30.89 | 26074081 | |
96 | Phosphorylation | GTGELDLTATQLSQG CCCCCCEEEEEECCC | 27.59 | 27251275 | |
98 | Phosphorylation | GELDLTATQLSQGAN CCCCEEEEEECCCCC | 25.47 | 27251275 | |
101 | Phosphorylation | DLTATQLSQGANGWQ CEEEEEECCCCCCEE | 19.42 | 17609267 | |
111 | Phosphorylation | ANGWQIISSSSGATP CCCEEEEECCCCCCC | 26.29 | 20873877 | |
112 | Phosphorylation | NGWQIISSSSGATPT CCEEEEECCCCCCCC | 20.36 | 20873877 | |
113 | Phosphorylation | GWQIISSSSGATPTS CEEEEECCCCCCCCC | 26.46 | 20873877 | |
114 | Phosphorylation | WQIISSSSGATPTSK EEEEECCCCCCCCCC | 34.10 | 20873877 | |
117 | Phosphorylation | ISSSSGATPTSKEQS EECCCCCCCCCCCCC | 30.53 | 20873877 | |
119 | Phosphorylation | SSSGATPTSKEQSGS CCCCCCCCCCCCCCC | 48.34 | 20873877 | |
120 | O-linked_Glycosylation | SSGATPTSKEQSGSS CCCCCCCCCCCCCCC | 35.08 | 16027160 | |
120 | Phosphorylation | SSGATPTSKEQSGSS CCCCCCCCCCCCCCC | 35.08 | 20873877 | |
126 | O-linked_Glycosylation | TSKEQSGSSTNGSNG CCCCCCCCCCCCCCC | 38.96 | 16027160 | |
128 | O-linked_Glycosylation | KEQSGSSTNGSNGSE CCCCCCCCCCCCCCC | 45.34 | 16027160 | |
134 | O-linked_Glycosylation | STNGSNGSESSKNRT CCCCCCCCCCCCCCE | 38.26 | 16027160 | |
254 | O-linked_Glycosylation | SGQTQYVTNVPVALN CCCCEEECCCCEEEC | 26.09 | 16027160 | |
265 | O-linked_Glycosylation | VALNGNITLLPVNSV EEECCCEEEEECCCC | 26.66 | 16027160 | |
271 | O-linked_Glycosylation | ITLLPVNSVSAATLT EEEEECCCCCEEEEC | 20.06 | 16027160 | |
273 | O-linked_Glycosylation | LLPVNSVSAATLTPS EEECCCCCEEEECCC | 16.41 | 16027160 | |
276 | O-linked_Glycosylation | VNSVSAATLTPSSQA CCCCCEEEECCCCCC | 30.77 | 16027160 | |
278 | Phosphorylation | SVSAATLTPSSQAVT CCCEEEECCCCCCEE | 19.44 | 22817900 | |
312 | O-linked_Glycosylation | ISSASLVSSQASSSS ECCHHCCCCCCCCCC | 23.25 | 16027160 | |
375 | Phosphorylation | LNIQQNQTSGGSLQA EECCCCCCCCCCCCH | 36.57 | 20068231 | |
376 | Phosphorylation | NIQQNQTSGGSLQAG ECCCCCCCCCCCCHH | 31.24 | 20068231 | |
379 | Phosphorylation | QNQTSGGSLQAGQQK CCCCCCCCCCHHCCC | 22.34 | 20068231 | |
394 | O-linked_Glycosylation | EGEQNQQTQQQQILI CCCCCHHHHHHHHHH | 20.69 | 16027160 | |
421 | O-linked_Glycosylation | ALQAAPLSGQTFTTQ HHHHCCCCCCEECCC | 28.00 | 16027160 | |
424 | O-linked_Glycosylation | AAPLSGQTFTTQAIS HCCCCCCEECCCCCC | 26.86 | 16027160 | |
446 | O-linked_Glycosylation | QLQAVPNSGPIIIRT CEECCCCCCCEEEEC | 39.62 | 16027160 | |
453 | O-linked_Glycosylation | SGPIIIRTPTVGPNG CCCEEEECCCCCCCC | 16.95 | 16027160 | |
453 | Phosphorylation | SGPIIIRTPTVGPNG CCCEEEECCCCCCCC | 16.95 | 14744793 | |
455 | O-linked_Glycosylation | PIIIRTPTVGPNGQV CEEEECCCCCCCCCE | 37.17 | 16027160 | |
491 | O-linked_Glycosylation | LAPMQGVSLGQTSSS EECCCCCCCCCCCCC | 33.34 | 16027160 | |
491 | O-linked_Glycosylation | LAPMQGVSLGQTSSS EECCCCCCCCCCCCC | 33.34 | 11371615 | |
507 | O-linked_Glycosylation | TTLTPIASAASIPAG CCCCCCCCCCCCCCC | 25.70 | 16027160 | |
510 | O-linked_Glycosylation | TPIASAASIPAGTVT CCCCCCCCCCCCEEE | 28.90 | 16027160 | |
517 | O-linked_Glycosylation | SIPAGTVTVNAAQLS CCCCCEEEECHHHHH | 14.10 | 16027160 | |
562 | Ubiquitination | ANAPGDHGAQLGLHG ECCCCCHHCCEECCC | 21.54 | 24816145 | |
575 | Ubiquitination | HGAGGDGIHDDTAGG CCCCCCCCCCCCCCC | 3.71 | 29967540 | |
576 | Ubiquitination | GAGGDGIHDDTAGGE CCCCCCCCCCCCCCC | 32.21 | 29967540 | |
579 | Phosphorylation | GDGIHDDTAGGEEGE CCCCCCCCCCCCCCC | 33.01 | 9153193 | |
588 | Phosphorylation | GGEEGENSPDAQPQA CCCCCCCCCCCCCCC | 21.61 | 26657352 | |
603 | Ubiquitination | GRRTRREACTCPYCK CCCCCHHHCCCCCCC | 7.66 | - | |
603 | Ubiquitination | GRRTRREACTCPYCK CCCCCHHHCCCCCCC | 7.66 | 24816145 | |
610 | Ubiquitination | ACTCPYCKDSEGRGS HCCCCCCCCCCCCCC | 59.45 | 24816145 | |
612 | O-linked_Glycosylation | TCPYCKDSEGRGSGD CCCCCCCCCCCCCCC | 27.69 | 16027160 | |
612 | Phosphorylation | TCPYCKDSEGRGSGD CCCCCCCCCCCCCCC | 27.69 | 16332679 | |
616 | Ubiquitination | CKDSEGRGSGDPGKK CCCCCCCCCCCCCCC | 47.00 | 29967540 | |
617 | Phosphorylation | KDSEGRGSGDPGKKK CCCCCCCCCCCCCCC | 38.37 | 20068231 | |
617 | Ubiquitination | KDSEGRGSGDPGKKK CCCCCCCCCCCCCCC | 38.37 | 29967540 | |
623 | Ubiquitination | GSGDPGKKKQHICHI CCCCCCCCCEEEEEE | 64.68 | 29967540 | |
624 | Ubiquitination | SGDPGKKKQHICHIQ CCCCCCCCEEEEEEE | 51.06 | 29967540 | |
640 | O-linked_Glycosylation | CGKVYGKTSHLRAHL CCCEECCCHHHHHHH | 19.60 | 16027160 | |
640 | Phosphorylation | CGKVYGKTSHLRAHL CCCEECCCHHHHHHH | 19.60 | 16332679 | |
641 | O-linked_Glycosylation | GKVYGKTSHLRAHLR CCEECCCHHHHHHHH | 24.82 | 16027160 | |
641 | Phosphorylation | GKVYGKTSHLRAHLR CCEECCCHHHHHHHH | 24.82 | 16332679 | |
645 | Ubiquitination | GKTSHLRAHLRWHTG CCCHHHHHHHHCCCC | 16.66 | 29967540 | |
651 | Phosphorylation | RAHLRWHTGERPFMC HHHHHCCCCCCCEEE | 33.50 | 22617229 | |
661 | Phosphorylation | RPFMCTWSYCGKRFT CCEEEEEEECCCCCC | 7.75 | 29083192 | |
668 | Phosphorylation | SYCGKRFTRSDELQR EECCCCCCCCHHHHH | 33.04 | 18258854 | |
670 | Phosphorylation | CGKRFTRSDELQRHK CCCCCCCCHHHHHHH | 32.17 | 25159151 | |
678 | Ubiquitination | DELQRHKRTHTGEKK HHHHHHHCCCCCCCC | 26.14 | - | |
679 | Phosphorylation | ELQRHKRTHTGEKKF HHHHHHCCCCCCCCC | 28.70 | - | |
681 | Phosphorylation | QRHKRTHTGEKKFAC HHHHCCCCCCCCCCC | 46.56 | 17049555 | |
685 | Ubiquitination | RTHTGEKKFACPECP CCCCCCCCCCCCCCC | 33.61 | - | |
686 | Ubiquitination | THTGEKKFACPECPK CCCCCCCCCCCCCCH | 14.50 | 29967540 | |
693 | 2-Hydroxyisobutyrylation | FACPECPKRFMRSDH CCCCCCCHHHHCCHH | 70.67 | - | |
693 | Ubiquitination | FACPECPKRFMRSDH CCCCCCCHHHHCCHH | 70.67 | 29967540 | |
698 | O-linked_Glycosylation | CPKRFMRSDHLSKHI CCHHHHCCHHHHHHH | 20.00 | 16027160 | |
698 | Phosphorylation | CPKRFMRSDHLSKHI CCHHHHCCHHHHHHH | 20.00 | 16332679 | |
702 | O-linked_Glycosylation | FMRSDHLSKHIKTHQ HHCCHHHHHHHHHHC | 20.83 | 16027160 | |
702 | Phosphorylation | FMRSDHLSKHIKTHQ HHCCHHHHHHHHHHC | 20.83 | 16332679 | |
703 | Acetylation | MRSDHLSKHIKTHQN HCCHHHHHHHHHHCC | 56.56 | 16478997 | |
707 | Phosphorylation | HLSKHIKTHQNKKGG HHHHHHHHHCCCCCC | 28.26 | - | |
720 | Phosphorylation | GGPGVALSVGTLPLD CCCCEEEEEEEEECC | 14.57 | - | |
723 | Phosphorylation | GVALSVGTLPLDSGA CEEEEEEEEECCCCC | 24.05 | - | |
728 | Phosphorylation | VGTLPLDSGAGSEGS EEEEECCCCCCCCCC | 37.92 | 18239466 | |
732 | Phosphorylation | PLDSGAGSEGSGTAT ECCCCCCCCCCCCCC | 37.95 | 18239466 | |
735 | Phosphorylation | SGAGSEGSGTATPSA CCCCCCCCCCCCCCC | 28.99 | 28348404 | |
737 | Phosphorylation | AGSEGSGTATPSALI CCCCCCCCCCCCCEE | 29.11 | 27251275 | |
739 | Phosphorylation | SEGSGTATPSALITT CCCCCCCCCCCEEEC | 20.02 | 11904305 | |
741 | Phosphorylation | GSGTATPSALITTNM CCCCCCCCCEEECCC | 31.21 | 28348404 | |
745 | Phosphorylation | ATPSALITTNMVAME CCCCCEEECCCCHHH | 16.99 | 28348404 | |
746 | Phosphorylation | TPSALITTNMVAMEA CCCCEEECCCCHHHH | 17.83 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
42 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
56 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
59 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
59 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
59 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
59 | S | Phosphorylation | Kinase | PRKCI | P41743 | GPS |
101 | S | Phosphorylation | Kinase | ATM | Q13315 | Uniprot |
101 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
278 | T | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
453 | T | Phosphorylation | Kinase | MAPK3 | P21708 | GPS |
453 | T | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
453 | T | Phosphorylation | Kinase | MAPK1 | P63086 | GPS |
453 | T | Phosphorylation | Kinase | MK03 | P27361 | PhosphoELM |
453 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
579 | T | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
579 | T | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
641 | S | Phosphorylation | Kinase | PKCZ | Q05513 | PSP |
651 | T | Phosphorylation | Kinase | PRKCZ | Q05513 | Uniprot |
668 | T | Phosphorylation | Kinase | PRKCZ | Q05513 | GPS |
670 | S | Phosphorylation | Kinase | PKCZ | Q05513 | PSP |
679 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
681 | T | Phosphorylation | Kinase | PKCZ | Q05513 | PSP |
698 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
702 | S | Phosphorylation | Kinase | PKCZ | Q05513 | PSP |
720 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
723 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
728 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
732 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
737 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
739 | T | Phosphorylation | Kinase | MK03 | P27361 | PhosphoELM |
739 | T | Phosphorylation | Kinase | MAPK3 | P21708 | GPS |
739 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
739 | T | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
739 | T | Phosphorylation | Kinase | MAPK1 | P63086 | GPS |
739 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
739 | T | Phosphorylation | Kinase | MK01 | P28482 | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:19372209 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
7 | S | Phosphorylation |
| 14593115 |
7 | S | ubiquitylation |
| 14593115 |
59 | S | Phosphorylation |
| 14593115 |
59 | S | Phosphorylation |
| 14593115 |
59 | S | Phosphorylation |
| 14593115 |
101 | S | Phosphorylation |
| 14593115 |
278 | T | Phosphorylation |
| 14593115 |
278 | T | ubiquitylation |
| 14593115 |
453 | T | Phosphorylation |
| 14593115 |
641 | S | Phosphorylation |
| 14593115 |
668 | T | Phosphorylation |
| 14593115 |
670 | S | Phosphorylation |
| 14593115 |
681 | T | Phosphorylation |
| 14593115 |
681 | T | Phosphorylation |
| 14593115 |
739 | T | Phosphorylation |
| 14593115 |
739 | T | Phosphorylation |
| 14593115 |
739 | T | ubiquitylation |
| 14593115 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SP1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Sp1 deacetylation induced by phorbol ester recruits p300 to activate12(S)-lipoxygenase gene transcription."; Hung J.J., Wang Y.T., Chang W.C.; Mol. Cell. Biol. 26:1770-1785(2006). Cited for: ACETYLATION AT LYS-703, INTERACTION WITH HDAC1; EP300 AND JUN,FUNCTION, AND MUTAGENESIS OF LYS-703. | |
O-linked Glycosylation | |
Reference | PubMed |
"Insulin dynamically regulates calmodulin gene expression bysequential O-glycosylation and phosphorylation of SP1 and itssubcellular compartmentalization in liver cells."; Majumdar G., Harrington A., Hungerford J., Martinez-Hernandez A.,Gerling I.C., Raghow R., Solomon S.; J. Biol. Chem. 281:3642-3650(2006). Cited for: GLYCOSYLATION AT SER-612; THR-640; SER-641; SER-698 AND SER-702,PHOSPHORYLATION, INDUCTION, SUBCELLULAR LOCATION, AND IDENTIFICATIONBY MASS SPECTROMETRY. | |
"O-linkage of N-acetylglucosamine to Sp1 activation domain inhibitsits transcriptional capability."; Yang X., Su K., Roos M.D., Chang Q., Paterson A.J., Kudlow J.E.; Proc. Natl. Acad. Sci. U.S.A. 98:6611-6616(2001). Cited for: GLYCOSYLATION AT SER-491, FUNCTION, AND MUTAGENESIS OF SER-491. | |
"O glycosylation of an Sp1-derived peptide blocks known Sp1 proteininteractions."; Roos M.D., Su K., Baker J.R., Kudlow J.E.; Mol. Cell. Biol. 17:6472-6480(1997). Cited for: GLYCOSYLATION AT SER-491, MUTAGENESIS OF SER-491, AND IDENTIFICATIONBY MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Phosphorylation by c-Jun NH2-terminal kinase 1 regulates thestability of transcription factor Sp1 during mitosis."; Chuang J.-Y., Wang Y.-T., Yeh S.-H., Liu Y.-W., Chang W.-C.,Hung J.-J.; Mol. Biol. Cell 19:1139-1151(2008). Cited for: PHOSPHORYLATION AT SER-59, FUNCTION, SUBCELLULAR LOCATION, ANDMUTAGENESIS OF SER-59; SER-73; THR-117; THR-278 AND THR-739. | |
"Angiotensin II-inducible platelet-derived growth factor-Dtranscription requires specific Ser/Thr residues in the second zincfinger region of Sp1."; Tan N.Y., Midgley V.C., Kavurma M.M., Santiago F.S., Luo X., Peden R.,Fahmy R.G., Berndt M.C., Molloy M.P., Khachigian L.M.; Circ. Res. 102:38-51(2008). Cited for: PHOSPHORYLATION AT THR-668; SER-670 AND THR-681, AND MUTAGENESIS OFTHR-668; SER-670 AND THR-681. | |
"Identification of phosphorylation sites on transcription factor Sp1in response to DNA damage and its accumulation at damaged sites."; Iwahori S., Yasui Y., Kudoh A., Sato Y., Nakayama S., Murata T.,Isomura H., Tsurumi T.; Cell. Signal. 20:1795-1803(2008). Cited for: PHOSPHORYLATION AT SER-101, FUNCTION, AND MUTAGENESIS OF SER-36;SER-56; SER-81; SER-85; THR-98; SER-101; THR-250; SER-281; SER-291;SER-296; SER-313; SER-351; THR-394; THR-427 AND SER-431. | |
"Phosphorylation mediates Sp1 coupled activities of proteolyticprocessing, desumoylation and degradation."; Spengler M.L., Guo L.W., Brattain M.G.; Cell Cycle 7:623-630(2008). Cited for: PHOSPHORYLATION AT SER-7 AND SER-59, SUMOYLATION AT LYS-16,PROTEOLYTIC PROCESSING, UBIQUITINATION, FUNCTION, AND MUTAGENESIS OFSER-7; SER-59; SER-728 AND SER-732. | |
"Phosphorylation of Sp1 in response to DNA damage by ataxiatelangiectasia-mutated kinase."; Olofsson B.A., Kelly C.M., Kim J., Hornsby S.M., Azizkhan-Clifford J.; Mol. Cancer Res. 5:1319-1330(2007). Cited for: PHOSPHORYLATION AT SER-101, FUNCTION, AND MUTAGENESIS OF SER-101. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASSSPECTROMETRY. | |
"Phosphatidylinositol 3-kinase/protein kinase Czeta-inducedphosphorylation of Sp1 and p107 repressor release have a critical rolein histone deacetylase inhibitor-mediated derepression oftranscription of the luteinizing hormone receptor gene."; Zhang Y., Liao M., Dufau M.L.; Mol. Cell. Biol. 26:6748-6761(2006). Cited for: PHOSPHORYLATION AT SER-641, FUNCTION, AND MUTAGENESIS OF SER-641. | |
"Increased chromatin association of Sp1 in interphase cells by PP2A-mediated dephosphorylations."; Vicart A., Lefebvre T., Imbert J., Fernandez A., Kahn-Perles B.; J. Mol. Biol. 364:897-908(2006). Cited for: PHOSPHORYLATION AT SER-59 AND THR-681, DEPHOSPHORYLATION,GLYCOSYLATION, FUNCTION, AND MUTAGENESIS OF SER-59; SER-220; THR-355;THR-453; THR-651; THR-681 AND THR-739. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-651, AND MASSSPECTROMETRY. | |
"HER-2/neu represses the metastasis suppressor RECK via ERK and Sptranscription factors to promote cell invasion."; Hsu M.C., Chang H.C., Hung W.C.; J. Biol. Chem. 281:4718-4725(2006). Cited for: PHOSPHORYLATION AT THR-453 AND THR-739, AND FUNCTION. | |
"Fibroblast growth factor-2 represses platelet-derived growth factorreceptor-alpha (PDGFR-alpha) transcription via ERK1/2-dependent Sp1phosphorylation and an atypical cis-acting element in the proximalPDGFR-alpha promoter."; Bonello M.R., Khachigian L.M.; J. Biol. Chem. 279:2377-2382(2004). Cited for: PHOSPHORYLATION AT THR-453 AND THR-739, FUNCTION, AND MUTAGENESIS OFTHR-453 AND THR-739. | |
"Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelialgrowth factor gene transcription."; Milanini-Mongiat J., Pouyssegur J., Pages G.; J. Biol. Chem. 277:20631-20639(2002). Cited for: PHOSPHORYLATION AT THR-453 AND THR-739, FUNCTION, AND MUTAGENESIS OFTHR-355; THR-453 AND THR-739. | |
Sumoylation | |
Reference | PubMed |
"Phosphorylation mediates Sp1 coupled activities of proteolyticprocessing, desumoylation and degradation."; Spengler M.L., Guo L.W., Brattain M.G.; Cell Cycle 7:623-630(2008). Cited for: PHOSPHORYLATION AT SER-7 AND SER-59, SUMOYLATION AT LYS-16,PROTEOLYTIC PROCESSING, UBIQUITINATION, FUNCTION, AND MUTAGENESIS OFSER-7; SER-59; SER-728 AND SER-732. | |
"Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatorydomain and inhibits Sp1-dependent transcription."; Spengler M.L., Brattain M.G.; J. Biol. Chem. 281:5567-5574(2006). Cited for: SUMOYLATION AT LYS-16, PROTEOLYTIC PROCESSING, AND MUTAGENESIS OFLYS-16; GLU-18 AND LYS-19. |